NCT03951129

Brief Summary

Determination of anxiety levels after verbal and video informing before hemodialysis catheter insertion

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 27, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 15, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2019

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

7 months

First QC Date

May 10, 2019

Last Update Submit

May 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • The State-Trait Anxiety Inventory (STAI) and Visual Analogue Scale (VAS) levels

    The State-Trait Anxiety Inventory (STAI):To measure via self-report the presence and severity of current symptoms of anxiety and a generalized propensity to be anxious. The STAI has 40 items, 20 items allocated to each of the S-Anxiety and T-Anxiety subscales. Range of scores for each subtest is 20-80, the higher score indicating greater anxiety. A cut point of 39-40 has been suggested to detect clinically significant symptoms for the S-Anxiety scale Visual Analogue Scale (VAS): The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations. Using a ruler, the score is determined by mea-surging the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)

    10 minute

Study Arms (2)

verbal group

The State-Trait Anxiety Inventory (STAI) and Visual Analogue Scale (VAS) levels after verbal informing before hemodialysis catheter insertion

Procedure: hemodialysis catheter insertion

verbal and video group

The State-Trait Anxiety Inventory (STAI) and Visual Analogue Scale (VAS) levels after verbal and video informing before hemodialysis catheter insertion

Procedure: hemodialysis catheter insertion

Interventions

The State-Trait Anxiety Inventory (STAI) and Visual Analogue Scale (VAS) scoring will be performed after informing all groups and after the procedure

verbal and video groupverbal group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study was planned to receive 84 people. The people to be recruited will be divided into groups. 1. the group will only be informed verbally. 2. The group will be informed as both verbal and video. State-Trait Anxiety Inventory and VAS score will be made after informing all groups and after Hemodialysis Catheter Insertion

You may qualify if:

  • Between the ages of 18 -65
  • Agree to participate ın the study
  • No need for emergency hemodialysis
  • No previously known psychiatric disorder
  • No history of hemodialysis before
  • No history of surgical procedures

You may not qualify if:

  • Refusing to participate ın the study
  • \<18 years of age and \>65 years
  • Need emergency dialysis
  • The presence of previously known psychiatric disorder
  • Presence of dialysis and catheter
  • Presence of a history of surgical procedure
  • Lack of information and documents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aksaray Universty

Aksaray, 68100, Turkey (Türkiye)

RECRUITING

Study Officials

  • Hüseyin Mutlu, MD

    Aksaray/Turkey

    STUDY DIRECTOR

Central Study Contacts

Hüseyin Mutlu, MD

CONTACT

Ekrem Taha Sert, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof. Dr. Principal Investigator

Study Record Dates

First Submitted

May 10, 2019

First Posted

May 15, 2019

Study Start

November 27, 2018

Primary Completion

June 27, 2019

Study Completion

August 27, 2019

Last Updated

May 20, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations